Exchange: OTC·Updated 09:30 AM EDT

SCPX Scorpius Holdings Inc.

$0.001
$0.0011
(52.38%)
Today
Reported EarningsApr 30
Mkt Cap$61,143.00
Vol509.00

About SCPX

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in San Antonio, TX.
54

Neutral Sentiment

How do you feel about SCPX?

Advertisement|Remove ads.